Sylejman Rexhepi
Overview
Explore the profile of Sylejman Rexhepi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
365
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Qorolli M, Rexhepi B, Rexhepi S, Mustapic M, Doko I, Grazio S
Rheumatol Int
. 2019 Mar;
39(5):827-834.
PMID: 30847560
Routine assessment of patient index data 3 (RAPID3) is a simple, valid and reliable tool designed to measure disease activity in patients with rheumatoid arthritis (RA). RA causes significant disability...
2.
Rexhepi S, Rexhepi M, Rexhepi B, Sahatciu-Meka V, Mahmutaj V
Open Access Maced J Med Sci
. 2018 Jun;
6(5):786-789.
PMID: 29875847
Aim: This study aims to evaluate the efficacy of Methotrexate (MTX) alone and combined therapy with Etanercept (ETN) and Methotrexate in patients with active rheumatoid arthritis (RA). Methods: In the...
3.
Rexhepi S, Rexhepi M, Sahatciu-Meka V, Rexhepi B, Bahtiri E, Mahmutaj V
Reumatizam
. 2018 Apr;
63(1):1-5.
PMID: 29616535
Rheumatoid arthritis (RA) may have an onset at older age. The onset of the disease at the age of 60 and
over is called late-onset rheumatoid arthritis (LORA). The aim...
4.
Bajraktari I, Krasniqi B, Rexhepi S, Bexheti S, Bahtiri E, Bajraktari H, et al.
Open Access Maced J Med Sci
. 2018 Mar;
6(2):336-339.
PMID: 29531599
Background: Rheumatoid arthritis (RA) is an autoimmune inflammatory disease characterised by intra-articular and extra-articular manifestations but very rarely with coxitis. Aim: This study aimed to investigate the prevalence of coxitis,...
5.
Bajraktari I, Rexhepi S, Berisha I, Lahu A, Kryeziu A, Durmishi B, et al.
Open Access Maced J Med Sci
. 2017 Sep;
5(5):641-644.
PMID: 28932306
Background: Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease that worsens during the course of the disease and can cause disability. Early RA refers to the onset of symptoms...
6.
Qorolli M, Hundozi-Hysenaj H, Rexhepi S, Rehxepi B, Grazio S
Clin Rheumatol
. 2016 Dec;
36(6):1379-1385.
PMID: 28028685
The Routine Assessment of Patient Index Data 3 (RAPID3) is a patient-reported disease activity measure used to assess physical function, pain, and global health in patients with rheumatoid arthritis (RA)...
7.
Rexhepi S, Rexhepi M, Sahatciu-Meka V, Mahmutaj V, Boshnjaku S
Med Arch
. 2016 May;
70(2):101-3.
PMID: 27147781
Introduction: Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by symmetrical polyarthritis and multisystemic involvement. Objective: The aim of this study was to assess the impact of low dose...
8.
Sahatciu-Meka V, Rexhepi S, Manxhuka-Kerliu S, Pallaska K, Murtezani A, Osmani-Vllasolli T, et al.
Reumatizam
. 2016 Feb;
62(1):6-11.
PMID: 26891576
The purpose of this study was to explore the relationship between disability status and duration of morning stiffness in hands with regard to age, level of education, and gender in...
9.
Rexhepi S, Bahtiri E, Rexhepi M, Sahatciu-Meka V, Rexhepi B
Mater Sociomed
. 2015 Nov;
27(4):259-62.
PMID: 26543419
Background And Objective: Body weight and body mass index (BMI) are considered potentially modifiable determinants of bone mass. Therefore, the aim of this study was to explore the association between...
10.
Bahtiri E, Islami H, Hoxha R, Qorraj-Bytyqi H, Rexhepi S, Hoti K, et al.
J Bone Miner Metab
. 2015 Jul;
34(5):571-9.
PMID: 26209167
Because of the efficacy of proton pump inhibitors (PPIs), their the use is increasing dramatically. The risk of adverse effects of short-term PPI therapy is low, but there are important...